Impact BioMedical Inc. (IBO)
NYSEAMERICAN: IBO · Real-Time Price · USD
5.14
+0.37 (7.76%)
Nov 13, 2026, 4:00 PM EST - Market closed
Impact BioMedical Market Cap
Impact BioMedical has a market cap or net worth of $43.91 million as of November 13, 2026. It is the 30,853rd most valuable company in the world and the 4,651st biggest in the United States. Its market cap has decreased by 19.39% in one year.
Market Cap
43.91M
Enterprise Value
43.89M
1-Year Change
-19.39%
Global Rank
Country Rank
#4,651 United States
Category
ChartMarket Cap Chart
Since the IPO on September 16, 2024, Impact BioMedical's market cap has increased from $34.49M to $43.91M, an increase of 27.31%. That is a compound annual growth rate of 11.84%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 43.91M | -16.88% |
| Dec 31, 2025 | 52.83M | 216.74% |
| Dec 31, 2024 | 16.68M | -51.64% |
| Sep 16, 2024 | 34.49M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Rein Therapeutics | 47.63M |
| Oncolytics Biotech | 47.18M |
| iBio, Inc. | 47.05M |
| MindWalk Holdings | 46.64M |
| Gain Therapeutics | 45.39M |
| Pliant Therapeutics | 43.16M |
| Connect Biopharma Holdings | 42.65M |
| Elicio Therapeutics | 42.46M |